Appeals Court Invalidates Bristol-Myers Squibb's Hep B Patent

In a win for the generic drug company Teva Pharmaceuticals and its lawyers at Winston & Strawn, the Federal Circuit knocked out a Bristol-Myers Squibb patent on the Hepatitis B drug Baraclude.

Sign up for a free trial now!'s Elite 15-day trial gives you:

  • All access pass to legal news across ALM's Network
  • News by Practice Area, available exclusively on
  • The free InPractice digital newsletter
  • Personalized legal news on the mobile App

During and after your trial, you'll receive the benefits of an ALM digital membership, including a subscription to the Newswire digital newsletter.